Expertise in
2
conditions

Minako Tomiita

Chiba, JP 
Expertise in
2
conditions
Chiba, JP 

Overview

Minako Tomiita practices practicing medicine in Chiba, Japan.

Ms. Tomiita is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Asthma in Children, Juvenile Idiopathic Arthritis (JIA), Dry Mouth, and Sjogren Syndrome.

She is actively involved in clinical research, co-authoring 40 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Chiba, Japan
Other Locations
Heta, 2660007, Japan
Yotsukaido, 2840003, Japan
Yotukaido City, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3

40 Total Publications

Multicentre, prospective, single-arm, non-controlled, open-label trial to evaluate the safety and efficacy of live attenuated influenza vaccine in paediatric patients with atopic dermatitis undergoing dupilumab therapy: a protocol.
Multicentre, prospective, single-arm, non-controlled, open-label trial to evaluate the safety and efficacy of live attenuated influenza vaccine in paediatric patients with atopic dermatitis undergoing dupilumab therapy: a protocol.
Journal: BMJ open
Published: August 03, 2025

Frequently Asked Questions about Minako Tomiita

Is Minako Tomiita a top-rated expert for Asthma in Children?

MediFind is an objective health platform that identifies experts based on real-world data. Minako Tomiita is classified as an Advanced expert for Asthma in Children, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Minako Tomiita participate in research or clinical trials?

Yes. Minako Tomiita has published 40 articles and abstracts on conditions like Asthma in Children. You can view a list of Minako Tomiita's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Tomiita's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile